IonQ, Inc. (NYSE:IONQ – Get Free Report) was down 3.7% on Tuesday . The stock traded as low as $37.59 and last traded at $37.87. Approximately 13,977,127 shares changed hands during trading, a decline of 44% from the average daily volume of 24,804,627 shares. The stock had previously closed at $39.31.
IonQ News Summary
Here are the key news stories impacting IonQ this week:
- Positive Sentiment: Drug-discovery partnership demonstrates practical progress. IonQ and QC Ware demonstrated a hybrid quantum-classical chemistry workflow using QC Ware’s Promethium platform and IonQ’s Forte trapped-ion system through Amazon Braket. The test produced enzyme active-site interaction-energy results within 4% of a benchmark, reportedly meeting the chemical-accuracy threshold for pharmaceutical research. This supports IonQ’s strategy of applying quantum computing to commercially relevant molecular modeling. QC Ware and IonQ Demonstrate High-Precision Hybrid Quantum Workflow for Drug Discovery
- Positive Sentiment: Expanded cloud accessibility could aid adoption. Running the workflow on IonQ Forte through Amazon Braket gives researchers access to the company’s hardware without requiring direct ownership, potentially broadening enterprise and pharmaceutical usage. The partnership also combines IonQ’s quantum hardware with GPU processing for more advanced molecular simulations. QC Ware and IonQ Demonstrate High-Precision Hybrid Quantum Workflow for Drug Discovery
- Neutral Sentiment: Analysts’ consensus target remains well above the recent trading level. A reported consensus price target of $69.92 suggests substantial upside in analyst models, although the target is not a new earnings forecast or guarantee and may reflect the stock’s highly speculative profile. IonQ Receives $69.92 Consensus Price Target from Analysts
- Negative Sentiment: Upcoming warrant expiration creates a potential overhang. IonQ’s outstanding public warrants are scheduled to expire on September 30, 2026. Warrant exercises before expiration could increase the share count and create dilution, while the expiration date may encourage additional trading activity and investor caution. IonQ Warrants Expire September 30 as Investors Watch for Potential Dilution
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on the company. Rosenblatt Securities reiterated a “buy” rating and issued a $100.00 price objective on shares of IonQ in a research note on Thursday, August 6th. Wedbush initiated coverage on shares of IonQ in a research note on Monday, August 3rd. They set an “outperform” rating and a $75.00 target price on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $70.00 target price on shares of IonQ in a report on Thursday, August 6th. Wall Street Zen downgraded shares of IonQ from a “sell” rating to a “strong sell” rating in a research note on Saturday, August 8th. Finally, Benchmark reiterated a “buy” rating and issued a $60.00 price target on shares of IonQ in a research note on Thursday, August 6th. Nine analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $69.92.
IonQ Stock Performance
The firm has a 50-day moving average price of $42.37 and a two-hundred day moving average price of $43.45. The firm has a market cap of $14.43 billion, a price-to-earnings ratio of -8.13 and a beta of 3.28.
IonQ (NYSE:IONQ – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported ($0.33) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.56) by $0.23. The firm had revenue of $80.05 million during the quarter, compared to the consensus estimate of $66.47 million. IonQ had a negative return on equity of 22.29% and a negative net margin of 553.27%.The firm’s quarterly revenue was up 286.7% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.70) earnings per share. Research analysts anticipate that IonQ, Inc. will post -2.86 earnings per share for the current year.
Insider Transactions at IonQ
In related news, Director Gabrielle B. Toledano sold 2,757 shares of IonQ stock in a transaction on Thursday, June 18th. The shares were sold at an average price of $55.01, for a total transaction of $151,662.57. Following the sale, the director directly owned 11,154 shares in the company, valued at $613,581.54. This trade represents a 19.82% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider John W. Raymond sold 3,815 shares of IonQ stock in a transaction on Thursday, June 18th. The stock was sold at an average price of $55.01, for a total transaction of $209,863.15. Following the sale, the insider owned 80,148 shares in the company, valued at $4,408,941.48. This represents a 4.54% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 9,329 shares of company stock worth $513,216. 0.55% of the stock is currently owned by insiders.
Hedge Funds Weigh In On IonQ
Large investors have recently bought and sold shares of the stock. California State Teachers Retirement System increased its position in shares of IonQ by 5,901.1% during the second quarter. California State Teachers Retirement System now owns 28,318,821 shares of the company’s stock worth $1,508,260,000 after purchasing an additional 27,846,924 shares in the last quarter. BlackRock Inc. acquired a new stake in shares of IonQ in the 2nd quarter valued at about $1,112,945,000. Bank of America Corp DE acquired a new stake in shares of IonQ in the 2nd quarter valued at about $344,757,000. Norges Bank purchased a new position in IonQ during the 4th quarter worth approximately $199,753,000. Finally, Marex Group plc grew its stake in IonQ by 419.1% during the 4th quarter. Marex Group plc now owns 4,083,453 shares of the company’s stock worth $183,225,000 after buying an additional 3,296,866 shares during the last quarter. Institutional investors and hedge funds own 41.42% of the company’s stock.
IonQ Company Profile
IonQ, Inc engages in the development of general-purpose quantum computing systems in the United States. It sells access to quantum computers of various qubit capacities. The company makes access to its quantum computers through cloud platforms, such as Amazon Web Services (AWS) Amazon Braket, Microsoft’s Azure Quantum, and Google’s Cloud Marketplace, as well as through its cloud service. It also provides contracts associated with the design, development, and construction of specialized quantum computing hardware systems; maintenance and support services; and consulting services related to co-developing algorithms on quantum computing systems.
Further Reading
- Five stocks we like better than IonQ
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for IonQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IonQ and related companies with MarketBeat.com's FREE daily email newsletter.
